Here is the latest stock price and chart of GSK Pharma. For more details, see the GSK Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
It's Our 25th Anniversary: Look What We Have for You...
Live BSE Quotes | Apr 23, 2021 (Close) | ||
---|---|---|---|
Price (Rs)1,451.35 | Open (Rs) 1,488.00 | High (Rs) 1,488.00 | Low (Rs) 1,444.80 |
% Change-0.42 | Volume 2,182 | Value (Rs) 3,187,186 | 52-Week H/L 1,805.00 / 1,258.00 |
Live NSE Quotes | Apr 23, 2021 (Close) | ||
---|---|---|---|
Price (Rs)1,451.95 | Open (Rs) 1,468.00 | High (Rs) 1,478.00 | Low (Rs) 1,450.00 |
% Change-0.38 | Volume 27,420 | Value (Rs) 40,040,651 | 52-Week H/L 1,807.50 / 1,206.00 |
Change | |||||
---|---|---|---|---|---|
1 Day -0.42% | 1 Month 2.23% | 3 Months -2.52% | 1 Year 0.28% | 5 Years (CAGR)* -4.48% | 10 Years (CAGR)* 3.24% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 28.50 | P/E Ratio (x) 50.93 | Market Cap (Rs m) 245,867.40 | P/BV (x) 11.49 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
GSK PHARMA last traded price was down 0.4% to Rs 1,451.4 on the BSE. On the NSE, GSK PHARMA last traded price was down 0.4% to Rs 1,452.0. The total volume of shares traded was 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 0.4%. And the benchmark S&P BSE SENSEX was at 47,878.5 (down 0.4%).
Over the last 30 days, the GSK PHARMA share price is up 1.8%. And over the last one year, GSK PHARMA share price is up 1.0%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed volatile trading activity throughout the day today and ended lower.
For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.
For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.
Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
In this video I tell you the three Nifty ETFs I think are the best.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
There is no stopping this 11-bagger stock from significant upside.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
More